TAK
Price
$15.19
Change
+$0.21 (+1.40%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
43.11B
35 days until earnings call
TKPHF
Price
$31.37
Change
+$0.10 (+0.32%)
Updated
Mar 27 closing price
Capitalization
47.94B
Ad is loading...

TAK vs TKPHF

Header iconTAK vs TKPHF Comparison
Open Charts TAK vs TKPHFBanner chart's image
Takeda Pharmaceutical
Price$15.19
Change+$0.21 (+1.40%)
Volume$33.27K
Capitalization43.11B
Takeda Pharmaceutical
Price$31.37
Change+$0.10 (+0.32%)
Volume$150
Capitalization47.94B
TAK vs TKPHF Comparison Chart
Loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TAK vs. TKPHF commentary
Apr 04, 2025

To understand the difference between Takeda Pharmaceutical Co - ADR (TAK) vs. Takeda Pharmaceutical Co (TKPHF) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (TAK: $14.98 vs. TKPHF: $31.37)
Brand notoriety: TAK and TKPHF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TAK: 67% vs. TKPHF: 5%
Market capitalization -- TAK: $43.11B vs. TKPHF: $47.94B
TAK [@Pharmaceuticals: Other] is valued at $43.11B. TKPHF’s [@Pharmaceuticals: Other] market capitalization is $47.94B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TAK’s FA Score shows that 1 FA rating(s) are green whileTKPHF’s FA Score has 1 green FA rating(s).

  • TAK’s FA Score: 1 green, 4 red.
  • TKPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, TKPHF is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TAK’s TA Score shows that 5 TA indicator(s) are bullish.

  • TAK’s TA Score: 5 bullish, 4 bearish.

Price Growth

TAK (@Pharmaceuticals: Other) experienced а -0.27% price change this week, while TKPHF (@Pharmaceuticals: Other) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.00%. For the same industry, the average monthly price growth was +65.26%, and the average quarterly price growth was -10.39%.

Reported Earning Dates

TAK is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-3.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.9B) has a higher market cap than TAK($43.1B). TAK has higher P/E ratio than TKPHF: TAK (36.79) vs TKPHF (22.47). TKPHF YTD gains are higher at: 17.279 vs. TAK (13.142). TKPHF has higher annual earnings (EBITDA): 1.15T vs. TAK (1.01T). TKPHF has more cash in the bank: 369B vs. TAK (317B). TAK (4.66T) and TKPHF (4.75T) have identical debt. TAK (4.17T) and TKPHF (4.11T) have equivalent revenues.
TAKTKPHFTAK / TKPHF
Capitalization43.1B47.9B90%
EBITDA1.01T1.15T88%
Gain YTD13.14217.27976%
P/E Ratio36.7922.47164%
Revenue4.17T4.11T101%
Total Cash317B369B86%
Total Debt4.66T4.75T98%
FUNDAMENTALS RATINGS
TAK vs TKPHF: Fundamental Ratings
TAK
TKPHF
OUTLOOK RATING
1..100
7550
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
8585
PRICE GROWTH RATING
1..100
4641
P/E GROWTH RATING
1..100
5348
SEASONALITY SCORE
1..100
5030

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (11) in the Pharmaceuticals Major industry is in the same range as TKPHF (11) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.

TAK's Profit vs Risk Rating (83) in the Pharmaceuticals Major industry is in the same range as TKPHF (100) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.

TAK's SMR Rating (85) in the Pharmaceuticals Major industry is in the same range as TKPHF (85) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.

TKPHF's Price Growth Rating (41) in the null industry is in the same range as TAK (46) in the Pharmaceuticals Major industry. This means that TKPHF’s stock grew similarly to TAK’s over the last 12 months.

TKPHF's P/E Growth Rating (48) in the null industry is in the same range as TAK (53) in the Pharmaceuticals Major industry. This means that TKPHF’s stock grew similarly to TAK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TAK
RSI
ODDS (%)
Bearish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
41%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 2 days ago
45%
Declines
ODDS (%)
Bearish Trend 4 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
53%
Aroon
ODDS (%)
Bullish Trend 2 days ago
42%
View a ticker or compare two or three
Ad is loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGC1.050.03
+2.94%
Canopy Growth Corp
DSP13.640.36
+2.71%
Viant Technology
TER83.621.01
+1.22%
Teradyne
CCOI61.65-0.01
-0.02%
Cogent Communications Holdings
BBGI5.53-0.20
-3.49%
Beasley Broadcast Group Inc

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TAK - TKPHF
27%
Poorly correlated
+0.54%
TEVJF - TKPHF
17%
Poorly correlated
N/A
ZTS - TKPHF
16%
Poorly correlated
+0.98%
BHC - TKPHF
15%
Poorly correlated
-2.24%
QNTM - TKPHF
13%
Poorly correlated
+0.63%
More